Basic Information
Glialign is developing a novel cell therapy for peripheral nerve repair—current treatments are successful in less than half of cases and often require nerve transplants from other parts of the body.
Glialign
London,England,United Kingdom
less than 15 people
January 01, 2017
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios